GNW earnings analysis
What we found in GNW's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
Genworth Financial reported Q1 2026 results with increased total revenue of $1.78B and EPS of $0.28, both exceeding expectations. The Enact segment showed strong growth with a 30% increase in new insurance written, while overall operating income fell slightly compared to the previous year. The balance sheet showed a reduction in cash and a marginal increase in assets, underscoring ongoing strategic investments in CareScout services.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Revenue Growth
- Total revenue for Q1 2026 was $1.78B, a slight decrease from $1.79B in Q4 2025, driven primarily by favorable Enact segment performance.
- Positive EPS Surprise
- EPS for Q1 2026 was $0.28, exceeding the estimated $0.20.
- Strong Enact Growth
- New insurance written increased 30% year-over-year to $12.79B in Q1 2026.
- Increased Net Investment Income
- Net investment income rose to $766M, up 4% from Q1 2025.
- Share Repurchase Program
- Genworth Financial repurchased $66M of its shares in Q1 2026, maintaining shareholder value.
- Stable Risk-to-Capital Ratio
- Enact's risk-to-capital ratio improved to 10.0:1, well below the maximum threshold.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Lower Operating Income
- Operating income decreased to $80M in Q1 2026 from $90M in Q1 2025, mainly due to increased claim expenses.
- Investment Losses
- Net investment losses for Q1 2026 were reported at $(26)M, significantly down from gains of $27M in Q1 2025.
- Regulatory Headwinds
- Changes in PMIERs could impact capital sufficiency in Enact's future operational performance.
What they reported.
What the company itself reported, taken out of the document.
- Earnings per share
- $0.28
- Segment
- Enact
- Segment
- Closed Block
What they said about what is next.
Outlook deferred to earnings press release / call.
The filing reads better than the one before it.
What came before.
- 10-K · February 27, 2026
- Genworth repositioned around two reportable segments (Enact and Closed Block) and is investing in CareScout while returning capital to shareholders: Enact returned $407 million to Genworth Holdings in 2025 and the…
- 10-Q · November 6, 2025
- Genworth reported Q3 2025 total revenues of $1,935 million, up $55 million (from $1,880 million) year-over-year, with income from continuing operations before income taxes of $164 million. Net income available to common…
- 10-Q · July 31, 2025
- Genworth reported quarterly revenues of $1,796 million (up $27 million vs Q2 2024) while income from continuing operations fell to $90 million (versus $111 million in Q2 2024), driving net income to $83 million (vs $110…
- 10-Q · May 2, 2025
- Genworth reported Q1 2025 total revenues of $1,786 million, down $78 million (−4.2%) from $1,864 million in Q1 2024, and diluted EPS to common shareholders declined to $0.13 (from $0.31). Operating profitability…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing GNW makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever